Published in Kardiol Pol on April 01, 2006
Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA (2011) 8.83
Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension (2013) 2.89
Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients. Hypertension (2008) 2.89
Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension (2010) 2.64
Comparison of aortic pulse wave velocity measured by three techniques: Complior, SphygmoCor and Arteriograph. J Hypertens (2008) 2.45
Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension (2011) 2.33
Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens (2010) 2.28
Fractional diastolic and systolic pressure in the ascending aorta are related to the extent of coronary artery disease. Am J Hypertens (2004) 2.21
Host and environmental determinants of heart rate and heart rate variability in four European populations. J Hypertens (2003) 1.70
The International Database of Ambulatory Blood Pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives. Blood Press Monit (2007) 1.62
How often pulmonary embolism mimics acute coronary syndrome? Kardiol Pol (2011) 1.58
Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. J Clin Lipidol (2013) 1.58
Reference values in white Europeans for the arterial pulse wave recorded by means of the SphygmoCor device. Hypertens Res (2006) 1.56
Epistatic interaction between alpha- and gamma-adducin influences peripheral and central pulse pressures in white Europeans. J Hypertens (2005) 1.55
Comparison of five electrocardiographic methods for differentiation of wide QRS-complex tachycardias. Europace (2012) 1.50
Outcome-driven thresholds for ambulatory pulse pressure in 9938 participants recruited from 11 populations. Hypertension (2013) 1.50
Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens (2012) 1.49
Risk stratification by 24-hour ambulatory blood pressure and estimated glomerular filtration rate in 5322 subjects from 11 populations. Hypertension (2012) 1.49
Peripheral blood concentrations of TGFβ1, IGF-1 and bFGF and remodelling of the left ventricle and blood vessels in hypertensive patients. Kardiol Pol (2010) 1.49
Doppler indexes of left ventricular systolic and diastolic function in relation to the arterial stiffness in a general population. J Hypertens (2016) 1.44
Blood pressure load does not add to ambulatory blood pressure level for cardiovascular risk stratification. Hypertension (2014) 1.44
Adipocytokines and blood pressure, lipids and glucose metabolism in hypertensive perimenopausal women. Kardiol Pol (2010) 1.44
Indices of autonomic nervous system activity in women with mild hypertension in the perimenopausal period. Kardiol Pol (2009) 1.42
Does sodium intake affect the relationship between blood pressure and vascular damage? Pol Arch Med Wewn (2015) 1.40
Relationship between left ventricular mass and the ACE D/I polymorphism varies according to sodium intake. J Hypertens (2004) 1.40
Increased prevalence of cardiovascular risk factors in patients with acute coronary syndrome and indications for treatment with oral anticoagulation. Kardiol Pol (2011) 1.40
Effects of device-guided slow breathing training on exercise capacity, cardiac function and respiratory patterns during sleep in male and female patients with chronic heart failure. Pol Arch Med Wewn (2017) 1.39
The effects of acute hyperglycaemia on the in-hospital and long-term prognosis in patients with an acute coronary syndrome--a pilot study. Kardiol Pol (2011) 1.39
Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction. Kardiol Pol (2013) 1.37
Towards Participatory Geographic Information Systems for community-based environmental decision making. J Environ Manage (2008) 1.35
Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension (2010) 1.35
A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens (2007) 1.22
Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press Monit (2002) 1.21
Arterial stiffness, pulse pressure, and cardiovascular disease-is it possible to break the vicious circle? Atherosclerosis (2011) 1.15
Determinants of poor hypertension management in patients with ischaemic heart disease. Blood Press (2005) 1.13
Prevalence of left ventricular diastolic dysfunction in European populations based on cross-validated diagnostic thresholds. Cardiovasc Ultrasound (2012) 1.06
Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension. Vasc Health Risk Manag (2011) 1.02
Blood pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome. Hypertens Res (2010) 0.98
Central blood pressure and hypertension: role in cardiovascular risk assessment. Clin Sci (Lond) (2009) 0.97
-391 C to G substitution in the regulator of G-protein signalling-2 promoter increases susceptibility to the metabolic syndrome in white European men: consistency between molecular and epidemiological studies. J Hypertens (2007) 0.96
Characteristics of electrocardiographic repolarization in acute myocardial infarction complicated by ventricular fibrillation. J Electrocardiol (2012) 0.93
Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation (2004) 0.92
Iodine-deficiency prophylaxis and the restriction of salt consumption - a 21st century challenge. Endokrynol Pol (2010) 0.92
Heritability and intrafamilial aggregation of arterial characteristics. J Hypertens (2008) 0.91
Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study. Eur J Prev Cardiol (2012) 0.90
Benefits of the RAS blockade: clinical evidence before the ONTARGET study. J Hypertens Suppl (2009) 0.90
The pulsatile component of blood pressure: its role in the pathogenesis of atherosclerosis. Blood Press (2007) 0.90
Sodium and potassium and the pathogenesis of hypertension. Curr Hypertens Rep (2013) 0.89
Are blood pressure and diabetes additive or synergistic risk factors? Outcome in 8494 subjects randomly recruited from 10 populations. Hypertens Res (2011) 0.89
Potential energy surface for interactions between two hydrogen molecules. J Chem Phys (2008) 0.87
Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension. Am J Hypertens (2003) 0.87
beta-Adducin polymorphisms, blood pressure, and sodium excretion in three European populations. Am J Hypertens (2003) 0.87
What do Polish interventional cardiologists know about indications and qualification for recanalisation of chronic total coronary artery occlusions? Kardiol Pol (2015) 0.87
Short-term blood pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO). Acta Cardiol (2011) 0.86
Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension. J Hypertens (2007) 0.86
Ascending aortic, but not brachial blood pressure-derived indices are related to coronary atherosclerosis. Atherosclerosis (2004) 0.86
Recanalisation of coronary chronic total occlusion by retrograde approach: the first experience in Poland. Kardiol Pol (2014) 0.85
Maternal and paternal influences on left ventricular mass of offspring. Hypertension (2003) 0.85
How many measurements are needed to estimate blood pressure variability without loss of prognostic information? Am J Hypertens (2013) 0.85
Age dependency of central and peripheral systolic blood pressures: cross-sectional and longitudinal observations in European populations. Blood Press (2011) 0.85
Double product reflects the predictive power of systolic pressure in the general population: evidence from 9,937 participants. Am J Hypertens (2013) 0.84
Effect of physical training on quality of life and oxygen consumption in patients with congestive heart failure. Int J Cardiol (2005) 0.84
Cross-sectional and longitudinal assessment of arterial stiffening with age in European and chinese populations. Front Physiol (2012) 0.84
Target sequencing, cell experiments, and a population study establish endothelial nitric oxide synthase (eNOS) gene as hypertension susceptibility gene. Hypertension (2013) 0.84
Age and gender dependent heart rate circadian model development and performance verification on the proarrhythmic drug case study. Theor Biol Med Model (2013) 0.83
Physical training in patients with chronic heart failure of ischemic origin: effect on exercise capacity and left ventricular remodeling. Eur J Cardiovasc Prev Rehabil (2007) 0.83
Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance. Metabolism (2007) 0.83
Genetic variation in CYP11B2 and AT1R influences heart rate variability conditional on sodium excretion. Hypertension (2004) 0.83
OASIS-HT: design of a pharmacogenomic dose-finding study. Pharmacogenomics (2005) 0.82
Pulmonary artery pulse wave velocity in idiopathic pulmonary arterial hypertension. Can J Cardiol (2012) 0.82
Electrophysiological study in a patient with Fabry disease and a short PQ interval. Europace (2006) 0.82
Second virial coefficients of H2 and its isotopologues from a six-dimensional potential. J Chem Phys (2012) 0.81
The new oral adenosine A1 receptor agonist capadenoson in male patients with stable angina. Clin Res Cardiol (2012) 0.81
Blood pressure phenotypes in relation to the beta-adducin C1797T polymorphism in the European Project on Genes in Hypertension (EPOGH). Blood Press Monit (2003) 0.80
Arterial characteristics in normotensive offspring of parents with or without a history of hypertension. Am J Hypertens (2006) 0.80
Postinfarction left ventricular pseudoaneurysm with left-to-right shunt: case report and review of the literature. Int J Cardiol (2008) 0.80
The influence of age on gender-specific differences in the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy. Int J Cardiol (2003) 0.80
Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial. J Hypertens (2010) 0.80
[Patient with left ventricular aneurysm and thrombus after myocardial infarction - long-term observation]. Kardiol Pol (2011) 0.80
Lipid-lowering drugs and homocysteine. A comparison between statins and other lipid-lowering drugs. Atherosclerosis (2004) 0.79
[Heart rate variability in offspring of hypertensive parents]. Przegl Lek (2002) 0.79
Polish Forum for Prevention Guidelines on Arterial Hypertension. Kardiol Pol (2007) 0.79
Effects of cardiac resynchronization therapy on sleep apnea, quality of sleep and daytime sleepiness in patients with chronic heart failure. Przegl Lek (2010) 0.79
Treatment of hypertension in the elderly in 2010 - a brief review. Expert Opin Pharmacother (2010) 0.79
Antihypertensive therapy and de-stiffening of the arteries. Expert Opin Pharmacother (2010) 0.79
Effects of slow deep breathing at high altitude on oxygen saturation, pulmonary and systemic hemodynamics. PLoS One (2012) 0.79
The influence of cardiac resynchronization therapy on selected inflammatory markers and aldosterone levels in patients with chronic heart failure. Przegl Lek (2011) 0.78
Clinical implications of non-invasive measurement of central aortic blood pressure. Curr Vasc Pharmacol (2010) 0.78
2015 guidelines for the management of hypertension. Recommendations of the Polish Society of Hypertension - short version. Kardiol Pol (2015) 0.78
Should dental treatment be considered for lowering inflammatory markers in hypertensive patients? Int J Cardiol (2007) 0.78
Secondary prevention in patients after hospitalisation due to coronary artery disease: what has changed since 2006? Kardiol Pol (2014) 0.78
Intraaortic pulse pressure amplification in subjects at high coronary risk. Hypertension (2010) 0.78